Esonap Tablet DR is a combination medication containing Naproxen 500 mg and Esomeprazole 20 mg, formulated to provide effective relief from inflammatory conditions while minimizing gastrointestinal side effects. Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), exerts analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis. It is commonly used in the management of conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain. However, NSAIDs like Naproxen are associated with an increased risk of gastrointestinal irritation, ulcers, and bleeding. To mitigate these adverse effects, Esomeprazole, a proton pump inhibitor (PPI), is included to suppress gastric acid secretion, promoting mucosal protection and healing. The delayed-release formulation ensures optimal absorption and targeted delivery of Esomeprazole to the intestine, enhancing its efficacy. Esonap Tablet DR should be used under medical supervision, especially in patients with a history of peptic ulcer disease, gastrointestinal bleeding, or renal impairment. Caution is advised in patients with cardiovascular risk factors. This combination therapy provides a balanced approach to managing pain and inflammation while safeguarding the gastrointestinal tract.